Australian court suppresses report questioning effectiveness of complementary remedy
BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7559.116-a (Published 13 July 2006) Cite this as: BMJ 2006;333:116
- Bob Burton
- Canberra
A Federal Court of Australia judge has granted an injunction sought by a complementary health company to temporarily suppress a report by a consumer watchdog group.
The report challenges claims that Tebonin, a product containing an extract of Ginkgo biloba, is an effective treatment for tinnitus.
In April 2006 Schwabe Pharma (Australia) launched a major marketing campaign in pharmacies, newspapers, and magazines promoting Tebonin for “tinnitus and vertigo relief.”
Tebonin contains an extract of Ginkgo biloba leaves called EGB761 and is made by the German company Dr Willmar Schwabe. On its website and in other …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.